Equillium, Inc. (EQ)

↓ Download CSV

CIK 0001746466 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-78.3%
Return on equity
Metric (FY)202520242023202220212020201920182017
Revenue$41.09M$36.08M$15.76M
Operating Income-$23.63M-$8.27M-$14.52M-$62.08M-$37.79M-$29.55M-$26.73M-$8.62M
Net Income-$22.40M-$8.07M-$13.34M-$62.43M-$39.05M-$29.81M-$25.60M-$13.25M
EPS (Diluted)$-0.39$-0.23$-0.38$-1.85$-1.36
Total Assets$31.89M$25.60M$50.53M$78.42M$85.41M$85.43M$55.54M$67.16M$7.15M
Total Liabilities$3.29M$6.54M$27.96M$46.48M$18.90M$15.57M$13.69M$2.23M$9.40M
Shareholders' Equity$28.60M$19.06M$22.57M$31.94M$66.50M$69.85M$41.85M$64.94M-$2.25M
Cash & Equivalents$30.28M$18.09M$23.22M$59.11M$50.37M$23.98M$13.22M$28.51M$7.10M
Operating Cash Flow-$22.75M-$19.03M-$21.78M-$8.73M-$32.08M-$24.62M-$22.95M-$7.53M
Capital Expenditures$48.0K$85.0K$50.0K$279.0K$57.0K$202.0K$74.0K$35.0K
Shares Outstanding61.46M35.56M35.25M34.41M29.46M24.75M17.43M17.38M10.71M